Fingerprint
Dive into the research topics of 'Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically